Bacthera

Bacthera was founded in 2019 as a joint venture of CHR. Hansen and Lonza, with offices in Switzerland and Denmark respectively.Bacthera is a one-stop CDMO for the development and manufacturing needs of biotherapeutic products. It integrates the development and supply of drug substances and drug products, from early development to the commercial supply of your live biotherapeutic products. Supported by specific product analytics, Bacthera provides customers with a risk-free CMC development process, with the overall goal of establishing a robust and scalable production process for commercialization. Bacthera offers integrated development services across the entire process chain of biotherapeutic products.